BUY State Bank of India — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)4 Nov 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·6 Nov · yesterday
24 other SEBI-registered advisors have active long-term BUY calls on this stock, with 8 issued in the last 14 days
Advisor consensus · same horizon·6 Nov · yesterday
SBI share price target: Jefferies, Motilal, others see up to 34% upside in state lender. Buy, sell or hold?
NewsEt-Markets·4 Nov · 3d ago
Loan growth, fall in provisions help SBI profits in Q2
NewsEt-Markets·3 Nov · 3d ago
State Bank of India reported Q2FY27 net profit of ₹23,038 crores, a 14.28% YoY increase. Net Interest Income grew 14.69% YoY, with improvements in asset quality as Gross NPA ratio declined to 1.39%.
BSE · Company Update·3 Nov · 4d ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on State Bank of India
- BUY — Somil Mehta, Sharekhan6 Nov 2026 · Next day · target ₹1,080 · Active
- BUY — Arun Kumar Mantri6 Nov 2026 · ~2 weeks · target ₹1,032 · Active
- BUY — Sumeet Bagadia, Choice Broking6 Nov 2026 · ~1 year · target ₹1,050 · Active
- BUY — Shrikant Chouhan, Kotak Securities6 Nov 2026 · Same day · target ₹1,030 · Expired
- BUY — Prakash Gaba5 Nov 2026 · Next day · target ₹1,030 · SL hit
More from ICICI Securities
- BUY ICICI Bank5 Nov 2026 · ~1 year · target ₹1,800 · Active
- BUY Stylam Industries5 Nov 2026 · ~1 year · target ₹3,750 · Active
- BUY Emcure Pharmaceuticals5 Nov 2026 · ~1 year · target ₹2,560 · Active
- BUY Saregama India5 Nov 2026 · ~1 year · target ₹740 · Active
- BUY Procter & Gamble Health4 Nov 2026 · ~1 year · target ₹6,680 · Active

